Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tepezza
Pharma
Amgen's products from buyout of Horizon continue to struggle
While Amgen’s legacy products are thriving, those gained from the company’s 2023 buyout of Horizon are struggling, especially blockbuster Tepezza.
Kevin Dunleavy
May 2, 2025 8:18am
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
Oct 31, 2024 7:50am
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Amgen lays out plan to boost sales of newly acquired Tepezza
Oct 31, 2023 11:29am
